Skip to content

A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation

A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05324540
Acronym
NAPC
Enrollment
30
Registered
2022-04-12
Start date
2022-04-30
Completion date
2023-03-31
Last updated
2022-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

An assessment of the use of cold therapy to terminate atrial fibrillation.

Interventions

OTHERCool therapy

Application of cool therapy. A chilled (between 5C and 10C) instrument will be applied to the oblique sinus while the patient is in atrial fibrillation.

Sponsors

MediCool Technologies
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be ≥ 18 years or older * Male of female * Subject has documented paroxysmal, or persistent atrial fibrillation (AF) with a history of less than one-year duration * Must be in AF at time of surgery, or inducible using manual or electrical stimulation * Subject is willing and able to provide written informed consent * Subject has a life expectancy of at least 1 year

Design outcomes

Primary

MeasureTime frameDescription
Termination of atrial fibrillationTermination will be measured within 3 minutes of application of cool therapy. No longer term data will be collected.Number of successful terminations of atrial fibrillation to normal sinus rhythm upon application of cool therapy will be measured and assessed.

Secondary

MeasureTime frameDescription
Time to terminationTime to termination will be assessed only during each application. No longer term data will be collected.The time it takes (in minutes and seconds) to terminate atrial fibrillation to normal sinus rhythm will be measured following application of cool therapy.

Contacts

Primary ContactJeff Rynbrandt
info@medicooltech.com231.645.2665

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026